Details:

Alternative Title:
Obesity (Silver Spring)
Publisher's site:
http://dx.doi.org/10.1002/oby.21258
Personal Author:
Braun, Joseph M. ; Chen, Aimin ; Romano, Megan E. ; Calafat, Antonia M. ; Webster, Glenys M. ; ... More +
Braun, Joseph M. ; Chen, Aimin ; Romano, Megan E. ; Calafat, Antonia M. ; Webster, Glenys M. ; Yolton, Kimberly ; Lanphear, Bruce P. ; Less -
Description:
Objective To examine relationships between prenatal perfluoroalkyl substance (PFAS) exposure and adiposity in children born to women who lived downstream from a fluoropolymer manufacturing plant. Methods Data are from a prospective cohort in Cincinnati, OH (HOME Study). We measured perfluorooctanoic (PFOA), perfluorooctane sulfonic (PFOS), perfluorononanoic (PFNA), and perfluorohexane sulfonic (PFHxS) acids in prenatal serum samples. We estimated differences in body mass index z-scores (BMI), waist circumference, and body fat at 8 years of age (n=204) and BMI between 2–8 years of age (n=285) according to PFAS concentrations. Results Children born to women in the top two PFOA terciles had greater adiposity at 8 years than children in the 1st tercile. For example, waist circumference (cm) was higher among children in the 2nd (4.3; 95% CI:1.7, 6.9) and 3rd tercile (2.2; 95% CI:−0.5, 4.9) compared to children in the 1st tercile. Children in the top two PFOA terciles also had greater BMI gains from 2–8 years compared to children in the 1st tercile (p<0.05). PFOS, PFNA and PFHxS were not associated with adiposity. Conclusions In this cohort, higher prenatal serum PFOA concentrations were associated with greater adiposity at 8 years and a more rapid increase in BMI between 2–8 years.
Subject:
[+]
Adiposity
Article
Children
Endocrine Disrupting Chemicals
Obesity
Obesogens
Perfluoroalkyl Substances

Source:
Obesity (Silver Spring). 24(1):231-237.
Pubmed ID:
26554535
Pubmed Central ID:
PMC4688224
Document Type:
Journal Article ;
Funding:
P01 ES011261/ES/NIEHS NIH HHS/United States ; P01 ES11261/ES/NIEHS NIH HHS/United States ; P30 ES006096/ES/NIEHS NIH HHS/United States ; R00 ES020 346/ES/NIEHS NIH HHS/United States ; R00 ES020346/ES/NIEHS NIH HHS/United States ; ... More +
P01 ES011261/ES/NIEHS NIH HHS/United States ; P01 ES11261/ES/NIEHS NIH HHS/United States ; P30 ES006096/ES/NIEHS NIH HHS/United States ; R00 ES020 346/ES/NIEHS NIH HHS/United States ; R00 ES020346/ES/NIEHS NIH HHS/United States ; R01 ES014575/ES/NIEHS NIH HHS/United States ; R01 ES020349/ES/NIEHS NIH HHS/United States ; R01 ES020349/ES/NIEHS NIH HHS/United States ; Less -
Collection(s):
CDC Public Access
Main Document Checksum:
[+]
urn:sha256:efeea2d31d08998ac45ceb93f2ee14fd8034339dab75bbb39b05d51385d94200
File Type:

Supporting Files

• 	nihms711823f3.jpg	jpeg
  	license.txt	txt
  	NIHMS711823-supplement-01.pdf	pdf
  	nihms711823.nxml	bin
  	nihms711823f1.gif	gif
  	nihms711823f1.jpg	jpeg
  	nihms711823f2.gif	gif
  	nihms711823f2.jpg	jpeg
  	nihms711823f3.gif	gif

More +